BUY 1 GET 1 50% OFF
no code needed

every product, sitewide — no code, applied automatically at checkout

side-by-side research comparison

Cagrilintide vs Tesamorelin

Cagrilintide and Tesamorelin are both studied in weight research, but they are different classes of compound with different reported research applications.

✓ both US-made · third-party tested · batch COA on every order

Last updated August 25, 2026

How do Cagrilintide and Tesamorelin differ?

Cagrilintide (Long-acting amylin analog peptide) is catalogued under weight & metabolic research; Tesamorelin (Synthetic GHRH analog · secretagogue research) is catalogued under weight & metabolic research. Verve lists 5 reported research applications for Cagrilintide and 4 for Tesamorelin. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.

Cagrilintide compared with Tesamorelin across compound class, research area, supply format, purity standard, documentation, catalog price and stock.
fieldCagrilintideTesamorelin
compound classLong-acting amylin analog peptideSynthetic GHRH analog · secretagogue research
research areaweight & metabolicweight & metabolic
reported research applications5 listed4 listed
supplied assingle compoundsingle compound
catalog sizes10mg20mg
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
endotoxin-tested optionnot offeredavailable
co-formulated together innot co-formulatednot co-formulated
price from$157.49$214.49
availabilityout of stockin stock

Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.

What is Cagrilintide and what is Tesamorelin?

Cagrilintide is classified as Long-acting amylin analog peptide; Tesamorelin as Synthetic GHRH analog · secretagogue research. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.

Cagrilintide

Long-acting amylin analog peptide

Cagrilintide is a synthetic long-acting analog of amylin, the pancreatic peptide co-secreted with insulin from beta cells. Its sequence is engineered for solubility and resistance to aggregation, and it carries a fatty-acid side chain that extends circulating half-life in pre-clinical systems, giving researchers a stable tool compound where native amylin is notoriously difficult to work with.

full Cagrilintide profile →

Tesamorelin

Synthetic GHRH analog · secretagogue research

Tesamorelin is a synthetic 44-amino-acid peptide, a stabilized analog of growth-hormone-releasing hormone (GHRH). Verve supplies it as a high-purity research compound for endocrine and secretagogue research.

full Tesamorelin profile →

Which research models is each compound studied in?

Cagrilintide and Tesamorelin both sit inside weight & metabolic research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for Cagrilintide and 4 for Tesamorelin. Rows are per compound, not equivalences.

Reported research applications listed for Cagrilintide and for Tesamorelin. Entries are listed per compound; a shared row is not a claim that the two applications are equivalent.
Cagrilintide — reported research applicationsTesamorelin — reported research applications
Amylin- and calcitonin-receptor agonism researchGHRH-receptor and secretagogue research
Calcitonin-receptor / RAMP complex pharmacology studiesEndocrine-signaling research models
Peptide aggregation, solubility, and stability researchPeptide pharmacokinetics and stability research
Metabolic-signaling research modelsMetabolic research models
Comparative studies alongside incretin-receptor reference compounds

Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.

What sizes and prices does verve list for Cagrilintide and Tesamorelin?

Cagrilintide is listed from $157.49 and Tesamorelin from $214.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.

Catalog sizes, single-vial prices and stock status for Cagrilintide and Tesamorelin.
compoundsize listedpriceavailability
Cagrilintide10mg$157.49out of stock
Tesamorelin20mg$214.49in stock
Cagrilintideout of stock
Tesamorelinfrom $214.49

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

shop the compounds →

Frequently asked questions about Cagrilintide and Tesamorelin

What is Cagrilintide?

Cagrilintide is a synthetic long-acting analog of the pancreatic peptide amylin, engineered for stability and extended half-life. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is Cagrilintide studied for in research?

It is used as a reference agonist in amylin- and calcitonin-receptor pharmacology, RAMP-complex research, and metabolic-signaling models in vitro and pre-clinically. Verve makes no health claims.

What is Tesamorelin?

Tesamorelin is a synthetic 44-amino-acid analog of growth-hormone-releasing hormone (GHRH). Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is Tesamorelin studied for in research?

It is used as a GHRH-receptor agonist model in secretagogue and endocrine-signaling research. Verve makes no human- or veterinary-use claims.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.